5 Stocks Under $10 With Solid Alpha Potential For Aggressive Traders
“With the number of new equity traders skyrocketing over the past year due to the Reddit/WallStreetBets popularity, locating good ideas to trade has become even…
stock market
As Small-Cap Stocks Outperform, Here Are 14 That Are Undervalued
“After lagging the broad market rebound in 2020, smaller companies staged a comeback in the latter part of that year and have been on a…
5 Biotech Stocks To Watch As The Industry Continues To Expand
“The biotech industry seems poised to continue its good run on the back of continued advancements in the field of research and subsequent speeding up…
3 Small-Cap Stocks With Big Potential
“While one could argue that small cap stocks are a bit riskier than large, well-funded behemoths, they’re also the place to look for the next…
Will Biotech Buck The Historical Trend This March? (And Where Will Biotech Go After 2021?)
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…
3 Tech Stocks With The Big Mo
“These are three top stocks for investors with plenty of risk tolerance to consider for aggressive growth portfolios,” says the author of today’s article of…
These Recent Insider Purchases Could Be Strong Signals To Potential Investors
When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares…
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
Feeling Bullish? These May Be “A Perfect Bet” Right Now For Outsized Returns
If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be…
With A Potential Solution To One Of The Biggest COVID Vaccine Problems, Could This Stock Be The Next Moderna?
This previously little-known immunotherapy stock recently saw its shares soar nearly 249% — and its market value surge from $300 million to more than $1…